Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
149M
-
Number of holders
-
466
-
Total 13F shares, excl. options
-
134M
-
Shares change
-
-1.49M
-
Total reported value, excl. options
-
$3.78B
-
Value change
-
-$110M
-
Put/Call ratio
-
0.78
-
Number of buys
-
187
-
Number of sells
-
-277
-
Price
-
$28.22
Significant Holders of Chemours Co - Common Stock, par value $0.01 per share (CC) as of Q4 2018
609 filings reported holding CC - Chemours Co - Common Stock, par value $0.01 per share as of Q4 2018.
Chemours Co - Common Stock, par value $0.01 per share (CC) has 466 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134M shares
of 149M outstanding shares and own 90.23% of the company stock.
Largest 10 shareholders include FMR LLC (24.4M shares), Vanguard Group Inc (17.6M shares), BlackRock Inc. (16.8M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (9.7M shares), STATE STREET CORP (5.29M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (3.18M shares), Bank of New York Mellon Corp (3.15M shares), LSV ASSET MANAGEMENT (3.08M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.92M shares), and Allianz Asset Management GmbH (2.21M shares).
This table shows the top 466 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.